I don't understand how the company can "be in very good shape"...

First 34 Last

Share
Profile

Follow
lucky_cat

422 Posts.

130

13/09/18

10:50

Post #: 35570243
Share

Originally posted by ape_of_god ↑

I wrote SAS prompting for a comment regarding when/if SAS intends to address funding and the plummeting SP. The response was as follows:

First of all, I thank you for being SAS shareholder and supporter, and apologize for the delay in response.
I and the founders/exec team are at World Space Business Week (WSBW) 2018 in Paris and it is a key global sat industry event. There could be a number of very positive commercial and financial relationships that come out of it, and we are aiming for that.

We remain fully on track for the launch of the first Pearl’s in mid 2019- no change to this. I was just in Australia the past week, providing updates on last year activities, achievements we had and the Pearls schedule which is progressing as expected.

We do understand and appreciate the market nervousness and concern to all risk capital right now, and the situation re SAS funding. We are working on this and believe to be closing some major commercial contracts as we have been over the past few weeks.

The company is in very good shape, and if there wasn’t the funding query I believe the market sentiment was different.
We are fully aware of this and working on it as priority 1.

Hope that helps.
Meir Moalem

Expand

I don't understand how the company can "be in very good shape" despite the 'funding query'?
It's not a funding 'query' Meir - without funding the company is in very bad shape.

How the CEO can trivially discuss funding as though it's a pesky side issue is beyond me.

SAS Price at posting: 4.8¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SGP

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PAM

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

RAD

Radiopharm extends radioimmunotherapy trial to 5 more cancer types